Condition
Idiopathic Ventricular Fibrillation clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Idiopathic Ventricular Fibrillation clinical trials that are recruiting, at sites in 3 countries (most in Denmark (1), Canada (1), Netherlands (1)). By phase: Phase 4 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 3Countries
All recruiting trials (2)
-
Low-dose beta-blocker treatment for adults who survived unexplained ventricular fibrillation
This trial will try low-dose beta-blockers in adults who survived an out-of-hospital cardiac arrest with no clear cause to see if it reduces dangerous heart rhythms and ICD therapies.
-
Anti-TREK-1 Autoantibodies in SCVF: A Multicenter Look
Researchers are testing whether anti-TREK-1 autoantibodies are linked to short-coupled ventricular fibrillation and if they can help diagnose or predict outcomes in adults with SCVF.
Related topics
Quick answers
How many Idiopathic Ventricular Fibrillation clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in Denmark (1 trial), Canada (1 trial), Netherlands (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.